Micetinoftalmina

Chloramphenicol, the active ingredient in Micetinoftalmina, is an amphenicol presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye, such as conjunctivitis and keratitis, in adult and pediatric patients.

GNH USA supplies Micetinoftalmina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable logistics for bulk and parcel orders. Customers benefit from consistent product quality, regulatory documentation, and responsive technical support throughout the supply chain.

Micetinoftalmina (chloramphenicol) is an antibacterial agent used to treat bacterial infections of the eye. - Bacterial conjunctivitis: Reduces bacterial load and accelerates resolution of redness, discharge, and irritation. - Keratitis: Controls bacterial proliferation in corneal infection, promoting healing and preventing scarring. - Other ophthalmic bacterial infections: Provides broad‑spectrum coverage for ocular pathogens causing blepharitis, ulcerative keratitis, or postoperative infections.

Chloramphenicol eye drops may cause local and systemic adverse reactions, although most patients tolerate the medication well.

Common Side Effects: - Eye irritation: Stinging or burning sensation upon instillation. - Redness: Mild conjunctival hyperemia. - Tearing: Increased lacrimation. - Blurred vision: Transient visual disturbance after dosing.

Serious or Rare Side Effects: - Allergic reaction: Swelling, rash, or hives indicating hypersensitivity. - Hematologic toxicity: Rare aplastic anemia or bone‑marrow suppression. - Stevens‑Johnson syndrome: Severe mucocutaneous eruption. - Contact lens intolerance: Discomfort requiring removal.

When using Micetinoftalmina, clinicians should observe several safety considerations to minimize risks. - Pregnancy: Category C; use only if potential benefit justifies potential fetal risk. - Breastfeeding: Caution; chloramphenicol may be excreted in milk and could affect the infant. - Allergy: Discontinue immediately if signs of hypersensitivity such as rash or swelling appear. - Contact lens wearers: Remove lenses during treatment and re‑insert after dosing to avoid drug absorption. - Systemic absorption: Limit use to prescribed duration to reduce risk of systemic toxicity. - Store at room temperature: Keep in original container, protect from light and moisture.

Chloramphenicol can interact with other medications, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic aminoglycosides: May increase ototoxicity risk when combined with ocular absorption. - Systemic anticoagulants (e.g., warfarin): Chloramphenicol can potentiate anticoagulant effect, raising bleeding risk. - Concurrent ophthalmic antibiotics: May reduce overall antibacterial activity or cause antagonism.

Moderate Interactions (Monitor Closely): - Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): May heighten ocular irritation. - Systemic corticosteroids: Can mask signs of infection, requiring careful monitoring. - Alcohol: Rarely, systemic exposure may enhance central nervous system depression.